Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000912282-24-000829
Filing Date
2024-11-26
Accepted
2024-11-26 18:56:32
Documents
1
Period of Report
2024-11-25

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5195
  Complete submission text file 0000912282-24-000829.txt   7055
Mailing Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6
Business Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6 310-849-8060
Aptose Biosciences Inc. (Issuer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O APTOSE BIOSCIENCES INC. 251 CONSUMERS ROAD, SUITE 1105 TORONTO A6 M2J 4R3
Business Address
Rice William G. (Reporting) CIK: 0001761487 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32001 | Film No.: 241505879